Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay

Skin sensitization is an important aspect of safety assessment and is a key component in the toxicological evaluation of chemicals. alpha-Glycosyl isoquercitrin (AGIQ), is marketed in Japan as a food additive and is generally recognized as safe (GRAS) by the expert panel of the Flavor and Extract Ma...

Full description

Bibliographic Details
Main Authors: Puneet Vij, Douglas A. Donahue, Keith P. Burke, Shim-mo Hayashi, Robert R. Maronpot
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750022001366
_version_ 1811188561127407616
author Puneet Vij
Douglas A. Donahue
Keith P. Burke
Shim-mo Hayashi
Robert R. Maronpot
author_facet Puneet Vij
Douglas A. Donahue
Keith P. Burke
Shim-mo Hayashi
Robert R. Maronpot
author_sort Puneet Vij
collection DOAJ
description Skin sensitization is an important aspect of safety assessment and is a key component in the toxicological evaluation of chemicals. alpha-Glycosyl isoquercitrin (AGIQ), is marketed in Japan as a food additive and is generally recognized as safe (GRAS) by the expert panel of the Flavor and Extract Manufacturers Association (FEMA) in 2005 and the U.S. Food and Drug Administration (FDA) in 2007. The Local Lymph Node Assay (LLNA) was used to assess AGIQ’s potential to cause skin sensitization. Results indicate that no excessive irritation was observed after the irritation screen (ear swelling < 25 % and erythema score < 3) when AGIQ was tested at 5 %, 10 %, and 25 % in N, N-dimethyl formamide [DMF]. Based on lack of irritation, AGIQ was further evaluated at 10 %, 25 %, and 50 % in DMF in the main test resulting in stimulation indices of less than the positive threshold of 1.6 i.e., 1.2, 1.4, and 1.2 respectively. Therefore, AGIQ was not a dermal sensitizer in the LLNA.
first_indexed 2024-04-11T14:20:50Z
format Article
id doaj.art-1b5086f2eaa14955b8101213e898413d
institution Directory Open Access Journal
issn 2214-7500
language English
last_indexed 2024-04-11T14:20:50Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj.art-1b5086f2eaa14955b8101213e898413d2022-12-22T04:19:03ZengElsevierToxicology Reports2214-75002022-01-01912911296Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node AssayPuneet Vij0Douglas A. Donahue1Keith P. Burke2Shim-mo Hayashi3Robert R. Maronpot4MB Research Laboratory, 1765 Wentz Road, Spinnerstown, PA 18968, USAIntegrated Laboratory Systems, Inc., PO Box 13501, Research Triangle Park, NC 27709, USAIntegrated Laboratory Systems, Inc., PO Box 13501, Research Triangle Park, NC 27709, USADivision of Food Additives, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, JapanMaronpot Consulting LLC, 1612 Medfield Road, Raleigh, NC 27607, USA; Corresponding author.Skin sensitization is an important aspect of safety assessment and is a key component in the toxicological evaluation of chemicals. alpha-Glycosyl isoquercitrin (AGIQ), is marketed in Japan as a food additive and is generally recognized as safe (GRAS) by the expert panel of the Flavor and Extract Manufacturers Association (FEMA) in 2005 and the U.S. Food and Drug Administration (FDA) in 2007. The Local Lymph Node Assay (LLNA) was used to assess AGIQ’s potential to cause skin sensitization. Results indicate that no excessive irritation was observed after the irritation screen (ear swelling < 25 % and erythema score < 3) when AGIQ was tested at 5 %, 10 %, and 25 % in N, N-dimethyl formamide [DMF]. Based on lack of irritation, AGIQ was further evaluated at 10 %, 25 %, and 50 % in DMF in the main test resulting in stimulation indices of less than the positive threshold of 1.6 i.e., 1.2, 1.4, and 1.2 respectively. Therefore, AGIQ was not a dermal sensitizer in the LLNA.http://www.sciencedirect.com/science/article/pii/S2214750022001366Alpha-glycosyl isoquercitrinAGIQIsoquercitrinSensitizationIrritationLocal Lymph Node Assay
spellingShingle Puneet Vij
Douglas A. Donahue
Keith P. Burke
Shim-mo Hayashi
Robert R. Maronpot
Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay
Toxicology Reports
Alpha-glycosyl isoquercitrin
AGIQ
Isoquercitrin
Sensitization
Irritation
Local Lymph Node Assay
title Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay
title_full Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay
title_fullStr Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay
title_full_unstemmed Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay
title_short Lack of skin sensitization hazard potential for alpha-glycosyl isoquercitrin (AGIQ) utilizing the Local Lymph Node Assay
title_sort lack of skin sensitization hazard potential for alpha glycosyl isoquercitrin agiq utilizing the local lymph node assay
topic Alpha-glycosyl isoquercitrin
AGIQ
Isoquercitrin
Sensitization
Irritation
Local Lymph Node Assay
url http://www.sciencedirect.com/science/article/pii/S2214750022001366
work_keys_str_mv AT puneetvij lackofskinsensitizationhazardpotentialforalphaglycosylisoquercitrinagiqutilizingthelocallymphnodeassay
AT douglasadonahue lackofskinsensitizationhazardpotentialforalphaglycosylisoquercitrinagiqutilizingthelocallymphnodeassay
AT keithpburke lackofskinsensitizationhazardpotentialforalphaglycosylisoquercitrinagiqutilizingthelocallymphnodeassay
AT shimmohayashi lackofskinsensitizationhazardpotentialforalphaglycosylisoquercitrinagiqutilizingthelocallymphnodeassay
AT robertrmaronpot lackofskinsensitizationhazardpotentialforalphaglycosylisoquercitrinagiqutilizingthelocallymphnodeassay